Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

therapeutic target

  • You have access
    Silencing lnc-ASAH2B-2 Inhibits Breast Cancer Cell Growth via the mTOR Pathway
    JINGJING LI, JING ZHANG, LIANG JIN, HERAN DENG and JIANNAN WU
    Anticancer Research June 2018, 38 (6) 3427-3434; DOI: https://doi.org/10.21873/anticanres.12611
  • You have access
    NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
    IORI NAGAMATSU, HIDEYA ONISHI, SHOJIRO MATSUSHITA, MAKOTO KUBO, MASAYA KAI, AKIRA IMAIZUMI, KENJI NAKANO, MASAMI HATTORI, YOSHINAO ODA, MASAO TANAKA and MITSUO KATANO
    Anticancer Research January 2014, 34 (1) 69-80;

Pages

  • Previous
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire